ABCA3 was previously identified as an ER-regulated gene [35], which supports its involvement in breast tumorigenesis, and SPTAN1 was involved in chemotherapy resistance in ovarian cancer [36], which makes this gene a potential target for cancer treatment. This evidence concerns the gene ABCA3 and ovarian cancer.